Last 12 months
Inside the activity.
0 purchase rows · 101 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 10 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 13 |
| Aug 2026 | 0 | 19 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 7 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · derivative · entry 14 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,597 Underlying: Common Stock · 1,199 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Represents restricted stock units which correspond 1-for-1 with common stock. F12 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning on July 1, 2017, provided the Reporting Person remains continuously employed on each vesting date and there is no expiration date. F12 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning on July 1, 2017, provided the Reporting Person remains continuously employed on each vesting date and there is no expiration date. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 669 | $0.00 Strike: $28.38 | $0.00 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · derivative · entry 13 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,272 Underlying: Common Stock · 669 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F10 · derivative.exercise_date: The shares underlying the option exercised in this transaction were fully vested and exercisable. The originally granted options are exercisable in 8 equal semi-annual installments beginning on October 1, 2018, provided the Reporting Person remains continuously employed on each vesting date. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,931 | $0.00 Strike: $10.23 | $0.00 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · derivative · entry 12 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,195 Underlying: Common Stock · 1,931 shares Expires 2027-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F9 · derivative.exercise_date: The shares underlying the option exercised in this transaction were fully vested and exercisable. The originally granted options are exercisable in 48 equal monthly installments beginning on April 15, 2017, provided the Reporting Person remains continuously employed on each vesting date. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 530 | $0.00 Strike: $14.06 | $0.00 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · derivative · entry 11 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,483 Underlying: Common Stock · 530 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F8 · derivative.exercise_date: This stock option is fully exercisable. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
Tax withholdingCommon Stock | 639 | $111.21 | $71,063.19 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · nonDerivative · entry 10 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,278 F7 · kind: This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionCommon Stock | 1,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · nonDerivative · entry 9 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
SaleCommon Stock | 600 | $111.06 | $66,636.00 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · nonDerivative · entry 8 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,718 F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.84 to $111.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
SaleCommon Stock | 1,086 | $110.15 | $119,622.90 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · nonDerivative · entry 7 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,318 F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.75 to $110.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
SaleCommon Stock | 599 | $109.00 | $65,291.00 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · nonDerivative · entry 6 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,404 F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.67 to $109.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
SaleCommon Stock | 930 | $107.46 | $99,937.80 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · nonDerivative · entry 5 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,003 F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.12 to $108.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
SaleCommon Stock | 184 | $106.52 | $19,599.68 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · nonDerivative · entry 4 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,933 F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.10 to $107.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionCommon Stock | 669 | $28.38 | $18,986.22 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · nonDerivative · entry 3 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionCommon Stock | 1,931 | $10.23 | $19,754.13 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · nonDerivative · entry 2 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:03 UTC Amendment |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionCommon Stock | 530 | $14.06 | $7,451.80 |
DisclosureSEC source: 0001209191-20-041388 · doc4a.xml · nonDerivative · entry 1 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:49 UTC |
Silverman JoshDirector · President & CEO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 80,000 | $0.00 Strike: $10.62 | $0.00 |
DisclosureSEC source: 0001370637-20-000194 · wf-form4_159407572932665.xml · derivative · entry 10 Silverman Josh · CIK 0001525358 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,524,969 Underlying: Common Stock · 80,000 shares Expires 2027-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and subsequent sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2019. F8 · derivative.exercise_date: The shares underlying the option exercised in this transaction were fully vested and exercisable. 25% of the stock options became exercisable on May 4, 2018, with the remainder of the originally granted options exercisable in 36 equal monthly installments beginning on June 4, 2018, provided the Reporting Person remains continuously employed on each vesting date. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:49 UTC |
Silverman JoshDirector · President & CEO
|
SaleCommon Stock | 2,764 | $111.32 | $307,688.48 |
DisclosureSEC source: 0001370637-20-000194 · wf-form4_159407572932665.xml · nonDerivative · entry 7 Silverman Josh · CIK 0001525358 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This exercise and subsequent sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.125 to $111.505, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:49 UTC |
Silverman JoshDirector · President & CEO
|
SaleCommon Stock | 26,332 | $110.67 | $2,914,162.44 |
DisclosureSEC source: 0001370637-20-000194 · wf-form4_159407572932665.xml · nonDerivative · entry 6 Silverman Josh · CIK 0001525358 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,764 F1 · kind: This exercise and subsequent sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.105 to $111.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:49 UTC |
Silverman JoshDirector · President & CEO
|
SaleCommon Stock | 15,418 | $109.69 | $1,691,200.42 |
DisclosureSEC source: 0001370637-20-000194 · wf-form4_159407572932665.xml · nonDerivative · entry 5 Silverman Josh · CIK 0001525358 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,096 F1 · kind: This exercise and subsequent sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.11 to $110.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:49 UTC |
Silverman JoshDirector · President & CEO
|
SaleCommon Stock | 9,370 | $108.74 | $1,018,893.80 |
DisclosureSEC source: 0001370637-20-000194 · wf-form4_159407572932665.xml · nonDerivative · entry 4 Silverman Josh · CIK 0001525358 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,514 F1 · kind: This exercise and subsequent sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.11 to $109.095, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:49 UTC |
Silverman JoshDirector · President & CEO
|
SaleCommon Stock | 17,026 | $107.50 | $1,830,295.00 |
DisclosureSEC source: 0001370637-20-000194 · wf-form4_159407572932665.xml · nonDerivative · entry 3 Silverman Josh · CIK 0001525358 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,884 F1 · kind: This exercise and subsequent sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.095 to $108.065, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:49 UTC |
Silverman JoshDirector · President & CEO
|
SaleCommon Stock | 9,090 | $106.73 | $970,175.70 |
DisclosureSEC source: 0001370637-20-000194 · wf-form4_159407572932665.xml · nonDerivative · entry 2 Silverman Josh · CIK 0001525358 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,910 F1 · kind: This exercise and subsequent sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.10 to$107.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:49 UTC |
Silverman JoshDirector · President & CEO
|
Exercise / conversionCommon Stock | 80,000 | $10.62 | $849,600.00 |
DisclosureSEC source: 0001370637-20-000194 · wf-form4_159407572932665.xml · nonDerivative · entry 1 Silverman Josh · CIK 0001525358 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and subsequent sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2019. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 669 | $0.00 Strike: $28.38 | $0.00 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · derivative · entry 11 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,272 Underlying: Common Stock · 669 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F9 · derivative.exercise_date: The shares underlying the option exercised in this transaction were fully vested and exercisable. The originally granted options are exercisable in 8 equal semi-annual installments beginning on October 1, 2018, provided the Reporting Person remains continuously employed on each vesting date. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,931 | $0.00 Strike: $10.23 | $0.00 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · derivative · entry 10 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,195 Underlying: Common Stock · 1,931 shares Expires 2027-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F8 · derivative.exercise_date: The shares underlying the option exercised in this transaction were fully vested and exercisable. The originally granted options are exercisable in 48 equal monthly installments beginning on April 15, 2017, provided the Reporting Person remains continuously employed on each vesting date. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 530 | $0.00 Strike: $14.06 | $0.00 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · derivative · entry 9 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,483 Underlying: Common Stock · 530 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F7 · derivative.exercise_date: This stock option is fully exercisable. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
SaleCommon Stock | 600 | $111.06 | $66,636.00 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · nonDerivative · entry 8 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,718 F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.84 to $111.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
SaleCommon Stock | 1,086 | $110.15 | $119,622.90 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · nonDerivative · entry 7 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,318 F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.75 to $110.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
SaleCommon Stock | 599 | $109.00 | $65,291.00 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · nonDerivative · entry 6 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,404 F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.67 to $109.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
SaleCommon Stock | 930 | $107.46 | $99,937.80 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · nonDerivative · entry 5 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,003 F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.12 to $108.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
SaleCommon Stock | 184 | $106.52 | $19,599.68 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · nonDerivative · entry 4 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,933 F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.10 to $107.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionCommon Stock | 669 | $28.38 | $18,986.22 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · nonDerivative · entry 3 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionCommon Stock | 1,931 | $10.23 | $19,754.13 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · nonDerivative · entry 2 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:54 UTC |
PATEL GOYAL KRUTIChief Product Officer
|
Exercise / conversionCommon Stock | 530 | $14.06 | $7,451.80 |
DisclosureSEC source: 0001209191-20-041210 · doc4.xml · nonDerivative · entry 1 PATEL GOYAL KRUTI · CIK 0001770886 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 16:37 UTC |
KLEIN JONATHAN DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,861 | $0.00 Strike: $9.67 | $0.00 |
DisclosureSEC source: 0001209191-20-038929 · doc4.xml · derivative · entry 3 KLEIN JONATHAN D · CIK 0001070890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,861 shares Expires 2026-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2020. F2 · derivative.exercise_date: This stock option was fully exercisable. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 16:37 UTC |
KLEIN JONATHAN DDirector
|
SaleCommon Stock | 25,000 | $100.00 | $2,500,000.00 |
DisclosureSEC source: 0001209191-20-038929 · doc4.xml · nonDerivative · entry 2 KLEIN JONATHAN D · CIK 0001070890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,613 F1 · kind: This exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2020. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 16:37 UTC |
KLEIN JONATHAN DDirector
|
Exercise / conversionCommon Stock | 10,861 | $9.67 | $105,025.87 |
DisclosureSEC source: 0001209191-20-038929 · doc4.xml · nonDerivative · entry 1 KLEIN JONATHAN D · CIK 0001070890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2020. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:33 UTC |
WILSON FREDERICK RDirector
|
SaleCommon Stock | 1,711 | $101.06 | $172,913.66 |
DisclosureSEC source: 0001209191-20-038921 · doc4.xml · nonDerivative · entry 2 WILSON FREDERICK R · CIK 0001227688 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,434 F1 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.00 to $101.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:33 UTC |
WILSON FREDERICK RDirector
|
SaleCommon Stock | 98,289 | $100.52 | $9,880,010.28 |
DisclosureSEC source: 0001209191-20-038921 · doc4.xml · nonDerivative · entry 1 WILSON FREDERICK R · CIK 0001227688 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,145 F1 · kind: These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:36 UTC |
REIFF MELISSADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-038927 · doc4.xml · derivative · entry 3 REIFF MELISSA · CIK 0001589723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,300 Underlying: Common Stock · 25,000 shares Expires 2025-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and corresponding sale were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2020. F2 · derivative.exercise_date: 100% of this award was fully vested as of April 15, 2018. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:36 UTC |
REIFF MELISSADirector
|
SaleCommon Stock | 25,000 | $100.00 | $2,500,000.00 |
DisclosureSEC source: 0001209191-20-038927 · doc4.xml · nonDerivative · entry 2 REIFF MELISSA · CIK 0001589723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,434 F1 · kind: This exercise and corresponding sale were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2020. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 20:36 UTC |
REIFF MELISSADirector
|
Exercise / conversionCommon Stock | 25,000 | $16.00 | $400,000.00 |
DisclosureSEC source: 0001209191-20-038927 · doc4.xml · nonDerivative · entry 1 REIFF MELISSA · CIK 0001589723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and corresponding sale were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2020. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:45 UTC |
Simeone JillGeneral Counsel & Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,541 | $0.00 Strike: $14.72 | $0.00 |
DisclosureSEC source: 0001209191-20-038737 · doc4.xml · derivative · entry 8 Simeone Jill · CIK 0001581731 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,709 Underlying: Common Stock · 14,541 shares Expires 2027-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and corresponding sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2020. F7 · derivative.exercise_date: The shares underlying the option exercised in this transaction were fully vested and exercisable. 25% of the stock options became exercisable on July 3, 2018, with the remainder of the originally granted options exercisable in 36 equal monthly installments beginning on August 3, 2018, provided the Reporting Person remains continuously employed on each vesting date. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:45 UTC |
Simeone JillGeneral Counsel & Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,459 | $0.00 Strike: $12.46 | $0.00 |
DisclosureSEC source: 0001209191-20-038737 · doc4.xml · derivative · entry 7 Simeone Jill · CIK 0001581731 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,730 Underlying: Common Stock · 3,459 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and corresponding sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2020. F6 · derivative.exercise_date: The shares underlying the option exercised in this transaction were fully vested and exercisable. 25% of the stock options became exercisable on February 1, 2018, with the remainder of the originally granted options exercisable in 36 equal monthly installments beginning on March 1, 2018, provided the Reporting Person remains continuously employed on each vesting date. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:45 UTC |
Simeone JillGeneral Counsel & Secretary
|
SaleCommon Stock | 641 | $98.83 | $63,350.03 |
DisclosureSEC source: 0001209191-20-038737 · doc4.xml · nonDerivative · entry 6 Simeone Jill · CIK 0001581731 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,009 F1 · kind: These exercises and corresponding sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.76 to $98.875, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:45 UTC |
Simeone JillGeneral Counsel & Secretary
|
SaleCommon Stock | 8,165 | $97.94 | $799,680.10 |
DisclosureSEC source: 0001209191-20-038737 · doc4.xml · nonDerivative · entry 5 Simeone Jill · CIK 0001581731 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,650 F1 · kind: These exercises and corresponding sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.615 to $98.475, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:45 UTC |
Simeone JillGeneral Counsel & Secretary
|
SaleCommon Stock | 7,231 | $97.28 | $703,431.68 |
DisclosureSEC source: 0001209191-20-038737 · doc4.xml · nonDerivative · entry 4 Simeone Jill · CIK 0001581731 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,815 F1 · kind: These exercises and corresponding sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.61 to $97.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:45 UTC |
Simeone JillGeneral Counsel & Secretary
|
SaleCommon Stock | 1,963 | $96.34 | $189,115.42 |
DisclosureSEC source: 0001209191-20-038737 · doc4.xml · nonDerivative · entry 3 Simeone Jill · CIK 0001581731 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,046 F1 · kind: These exercises and corresponding sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.58 to $96.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:45 UTC |
Simeone JillGeneral Counsel & Secretary
|
Exercise / conversionCommon Stock | 14,541 | $14.72 | $214,043.52 |
DisclosureSEC source: 0001209191-20-038737 · doc4.xml · nonDerivative · entry 2 Simeone Jill · CIK 0001581731 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and corresponding sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2020. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 20:45 UTC |
Simeone JillGeneral Counsel & Secretary
|
Exercise / conversionCommon Stock | 3,459 | $12.46 | $43,099.14 |
DisclosureSEC source: 0001209191-20-038737 · doc4.xml · nonDerivative · entry 1 Simeone Jill · CIK 0001581731 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These exercises and corresponding sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2020. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 20:57 UTC |
Silverman JoshDirector · President & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $10.62 | $0.00 |
DisclosureSEC source: 0001209191-20-038508 · doc4.xml · derivative · entry 5 Silverman Josh · CIK 0001525358 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,604,969 Underlying: Common Stock · 5,000 shares Expires 2027-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and subsequent sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2019. F2 · derivative.exercise_date: The shares underlying the option exercised in this transaction were fully vested and exercisable. 25% of the stock options became exercisable on May 4, 2018, with the remainder of the originally granted options exercisable in 36 equal monthly installments beginning on June 4, 2018, provided the Reporting Person remains continuously employed on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.